» Articles » PMID: 17015232

Neurobiology of Schizophrenia

Overview
Journal Neuron
Publisher Cell Press
Specialty Neurology
Date 2006 Oct 4
PMID 17015232
Citations 272
Authors
Affiliations
Soon will be listed here.
Abstract

With its hallucinations, delusions, thought disorder, and cognitive deficits, schizophrenia affects the most basic human processes of perception, emotion, and judgment. Evidence increasingly suggests that schizophrenia is a subtle disorder of brain development and plasticity. Genetic studies are beginning to identify proteins of candidate genetic risk factors for schizophrenia, including dysbindin, neuregulin 1, DAOA, COMT, and DISC1, and neurobiological studies of the normal and variant forms of these genes are now well justified. We suggest that DISC1 may offer especially valuable insights. Mechanistic studies of the properties of these candidate genes and their protein products should clarify the molecular, cellular, and systems-level pathogenesis of schizophrenia. This can help redefine the schizophrenia phenotype and shed light on the relationship between schizophrenia and other major psychiatric disorders. Understanding these basic pathologic processes may yield novel targets for the development of more effective treatments.

Citing Articles

Schizophrenia and Bone Marrow Disorders: An Emerging Clinical Association.

Jayakumar J, Ginjupalli M, Kalaivani Babu A, Rajarajan S, Jakkam Setty M Cureus. 2025; 16(12):e75822.

PMID: 39816323 PMC: 11735017. DOI: 10.7759/cureus.75822.


Acute Behavioral and Neurochemical Effects of Sulpiride in Adult Zebrafish.

Galstyan D, Lebedev A, Ilyin N, Papulova M, Golushko N, Tishkina V Neurochem Res. 2024; 50(1):11.

PMID: 39549192 DOI: 10.1007/s11064-024-04268-9.


Impact of cannabinoids on synapse markers in an SH-SY5Y cell culture model.

Jahn K, Blumer N, Wieltsch C, Duzzi L, Fuchs H, Meister R Schizophrenia (Heidelb). 2024; 10(1):96.

PMID: 39448630 PMC: 11502758. DOI: 10.1038/s41537-024-00498-6.


State of the Art in Sub-Phenotyping Midbrain Dopamine Neurons.

Basso V, Dobrossy M, Thompson L, Kirik D, Fuller H, Gates M Biology (Basel). 2024; 13(9).

PMID: 39336117 PMC: 11428604. DOI: 10.3390/biology13090690.


What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia.

Correll C, Tusconi M, Carta M, Dursun S Biomolecules. 2024; 14(8).

PMID: 39199294 PMC: 11353083. DOI: 10.3390/biom14080906.